Several observational studies have described associations between different biomarkers with severe outcomes in COVID-19, including a meta-analysis of 32 studies reporting similar magnitudes of effect ranging from pooled OR 2.36 (thrombocytopenia) to 4.27 (elevated CRP).21 The gene discussed is CRP; the disease is COVID-19.